Treatment of Covid-19 Infection: The Hong Kong Experience

This abstract has open access
Abstract Description

The Covid-19 pandemic which commenced in December 2019 has resulted in more than 1.36 million confirmed cases, 2.9 million deaths and affected 192 countries. This pandemic of the century has once again reminded us the importance of infection control measures, research in the development of antiviral and vaccine against the emerging infectious diseases, but even more important, to respect the wild life in the nature. Various institutes, governments and pharmaceuticals have worked together to develop effective Covid-19 antivirals and vaccines. In Hong Kong, the tight infection control measures and the early quarantine of confirmed patients allow us to commence early treatment in high risk patients, thus optimizing the effect of the antiviral treatment. This resulted in effective suppression of patient’s viral load, hastened clinical recovery and reduced risk of deterioration. In this lecture, I will discuss the various treatment modalities in Covid-19 infection.


Abstract ID :
HAC6806
Submission Type
The University of Hong Kong

Abstracts With Same Type

Abstract ID
Abstract Title
Abstract Topic
Submission Type
Primary Author
HAC6808
Speaker
Dr. Paul Aarne KOLJONEN
HAC6775
Speaker
Dr. Wacy Wai-sze LUI
HAC6801
Speaker
Prof. Hung-fat TSE
HAC6793
Speaker
Mr. Kok-tin GAN
406 visits